Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report

Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report

Bibliographic Details
Main Authors:	Akihito Kawai, Sachiko Kawasaki, Tomoko Nishimura, Hideki Shigematsu, Masato Tanaka, Yasuhito Tanaka
Format:	Article
Language:	English
Published:	The Japanese Society for Spine Surgery and Related Research 2022-11-01
Series:	Spine Surgery and Related Research
Subjects:	bacillus calmette-guérin spondylodiscitis intravesical bcg therapy non-muscle-invasive bladder cancer immunocompromised state case report
Online Access:	https://www.jstage.jst.go.jp/article/ssrr/6/6/6_2022-0009/_pdf/-char/en

Similar Items

Two-stage posterior decompression and fusion for tuberculous spondylitis after intravesical bacillus Calmette-Guerin instillation
by: Hiroki Ohata, et al.
Published: (2021-01-01)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
by: Christopher James, et al.
Published: (2023-04-01)

Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
by: R. Waked, et al.
Published: (2020-05-01)

The impact of Bacillus Calmette-Guérin (BCG) vaccination on the course of COVID-19
by: Jakub Krzysztof Gałązka
Published: (2022-10-01)

Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy
by: Guven Aslan, et al.
Published: (2013-01-01)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
by: Suresh Bhat, et al.
Published: (2015-01-01)

Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
by: Paula Cíntia Machado Sampaio, et al.
Published: (2017-08-01)

Mycobacterium Bovis Spondylodiscitis: A Rare Complication of Intravesical Bacillus Calmette-Guérin Therapy
by: Frédéric Quatannens, et al.
Published: (2022-07-01)

An Investigation into Improvement of Stability and Efficacy of Intravesical BCG Formulations Using Freeze-Drying Technique
by: Hamidreza Hozouri, et al.
Published: (2021-01-01)

Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01)

Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer
by: Azharuddin Mohammed, et al.
Published: (2017-12-01)

Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I)
by: Yuvaraja B. Thyavihally, et al.
Published: (2022-04-01)

Disfunción orgánica múltiple como complicación de la instilación intravesical de bacilo de Calmette-Guérin
by: Eduardo Moreira, et al.
Published: (2019-07-01)

Breast abscess due to Bacillus Calmette-Guérin
by: Aurélien Dinh, et al.
Published: (2017-06-01)

Progressive Cerebral Small Vessel Disease Caused by an Autoimmune Response to Intravesical Bacille-Calmette-Guérin Treatment
by: Anouck Becker, et al.
Published: (2020-10-01)

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice
by: V.L. Petricevich, et al.
Published: (2001-01-01)

Effects of acupuncture to decrease adverse events in patients with high-risk non-muscle invasive bladder cancer receiving induction intravesical BCG therapy: Study protocol for a randomized, controlled pilot and feasibility study
by: Sarah P. Psutka, et al.
Published: (2022-12-01)

Disseminated Bacillus Calmette–Guérin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review
by: Gen Shimizu, et al.
Published: (2020-09-01)

Urethral fistula and perineal collection during intravesical treatment for non-muscle invasive bladder cancer – A rare complication
by: Katherine Ong, et al.
Published: (2022-05-01)

HUBUNGAN RIWAYAT STATUS IMUNISASI BACILLE CALMETTE-GUÉRIN (BCG) DENGAN KEJADIAN TUBERKULOSIS (TB) PADA ANAK DI BADAN LAYANAN UMUM DAERAH RUMAH SAKIT UMUM CUT MEUTIA ACEH UTARA TAHUN 2015
by: Hedya Nadhrati Surura, et al.
Published: (2018-02-01)

Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature
by: Oreoluwa Oladiran, et al.
Published: (2020-03-01)

Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study
by: Che-Wei Hsu, et al.
Published: (2020-07-01)

Economic impacts of the Bacillus Calmette-Guérin (BCG) therapy shortage and the proposed solutions for patients with non-muscle invasive bladder Cancer in Aseer Province, Saudi Arabia
by: Mishari H M Alshyarba, et al.
Published: (2020-01-01)

Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette–Guérin (BCG) immunotherapy
by: Nina Nielens, et al.
Published: (2022-04-01)

Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette-Guérin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective comparison
by: Teruo Inamoto, et al.
Published: (2013-01-01)

Secondary Haemophagocytic Lymphohistiocytosis Syndrome (HLH) After Intravesical Instillation of Bacillus Calmette-Guérin (BCG): A Case Report and Review of the Literature
by: Konstantinos Manganas, et al.
Published: (2022-10-01)

Evolution of the Bacillus Calmette-Guérin scar Russia and Moreau strains in newborns: A brazilian cohort
by: Ramon Andrade de Souza, et al.
Published: (2023-08-01)

Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
by: Eric K. Diner, et al.
Published: (2004-10-01)

Assessment of angiogenic factor, vascular endothelial growth factor, serum and urine level changes in superficial bladder tumor immunotherapy by intravesical Bacillus Calmette-Guerin
by: Kerigh Behzad, et al.
Published: (2010-01-01)

Late-onset granulomatous prostatitis following intravesical bacille Calmette-Guerin therapy: case report
by: Octavio Castillo Cádiz, et al.
Published: (2016-06-01)

New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette–Guerin
by: Chih-Tsung Hung, et al.
Published: (2012-09-01)

Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
by: Samuel T. Pasco, et al.
Published: (2020-09-01)

Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies
by: Makito Miyake, et al.
Published: (2021-05-01)

Mycobacterium bovis Osteomyelitis of the Thoracic Spine Mimicking a Metastatic Lytic Lesion in a Patient Exposed to Intravesicular Bacille Calmette-Guérin Treatment
by: Jessica R. Newman, et al.
Published: (2014-07-01)

DISSEMINATED BACILLUS-CALMETTE-GUÉRIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW
by: Rina Yue Ling Ong, et al.
Published: (2020-08-01)

Establishment of an in vitro model of monocyte-like THP-1 cells for trained immunity induced by bacillus Calmette-Guérin
by: Jin-Chuan Xu, et al.
Published: (2024-04-01)

Booster Dose of Bacille Calmette-Guérin Vaccine for Tuberculosis in Low and Middle-Income Countries: A Systematic Review
by: Oduwole OA, et al.
Published: (2021-09-01)

Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity
by: Bedeir Ali-El-Dein, et al.
Published: (2013-01-01)

Intravesical bacillus Calmette–Guérin-induced myopathy presenting as rhabdomyolysis: a case report
by: Chae Hun Lee, et al.
Published: (2023-10-01)